Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of RGT-274-CR capsules in obese adults in China
ChiCTR2600130711Phase 2Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing RGT-274-CR once daily with Placebo once daily (2 arms). Primary endpoint: Efficacy of once-daily oral RGT-274-CR in obese participants. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
RGT-274
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2600130711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130711.